SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001571049-17-001210
Filing Date
2017-02-10
Accepted
2017-02-10 16:07:50
Documents
1
Group Members
CELGENE CORP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G t1700375_sc13g.htm SC 13G 62685
  Complete submission text file 0001571049-17-001210.txt   64211
Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89831 | Film No.: 17593314
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AON HOUSE 30 WOODBOURNE AVENUE PEMBROKE D0 HM 08
Business Address AON HOUSE 30 WOODBOURNE AVENUE PEMBROKE D0 HM 08 4412964803
Celgene Switzerland LLC (Filed by) CIK: 0001661486 (see all company filings)

IRS No.: 475587373 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G